DONATE

4ª Jornada Anual del GIPS

El IBEC es el coorganizador de la Jornada Anual de este año, que se celebrará el próximo 17 de junio y lleva como título ‘Investigación traslacional en tecnología y salud’. La … Read more

Bioengineering in the Territory

The Bioengineering in the Territory project aims to decentralize scientific knowledge and promote scientific education in an equitable way across the region. We want to ensure that everyone, regardless of … Read more

New advances in the fight against the most common form of lung cancer

From left to right, Fernando Martín and Joan Montero at the Faculty of Medicine and Health Sciences. / Credit: University of Barcelona

A study led by the University of Barcelona in collaboraiton with the Institute for Bioengineering of Catalonia reveals that the functional assay dynamic BH3 profiling (DBP) can predict whether specific treatments will be effective in non-small cell lung cancer patients. The technique helps determine which therapy will be most effective by testing it directly on living cells, improving personalised therapies.

IBEC researcher Irene Marco-Rius receives Anatole Abragam Prize for her contributions to the field of magnetic resonance

Dr Irene Marco-Rius, principal investigator at the Institute for Bioengineering of Catalonia (IBEC), has been awarded the 2025 Anatole Abragam Prize for her pioneering work on the use of magnetic resonance to study cells grown on chips, allowing ex vivo metabolic assessment of disease mechanisms and therapy responses in controlled microenvironments. The award was presented at the Joint ENC-ISMAR Conference in California.